Source: Clinics. Unidade: FMRP
Subjects: INIBIDORES DE ENZIMAS, HEPATITE C, DOENÇA CRÔNICA, ESTUDOS MULTICÊNTRICOS
ABNT
CALLEFI, Luciana Azevêdo et al. Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study. Clinics, v. 72, n. 6, p. 378-385, 2017Tradução . . Disponível em: https://doi.org/10.6061/clinics/2017(06)08. Acesso em: 22 ago. 2024.APA
Callefi, L. A., Villela-Nogueira, C. A., Tenore, S. de B., Carnaúba-Júnior, D., Coelho, H. S. M., Pinto, P. de T. A., et al. (2017). Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study. Clinics, 72( 6), 378-385. doi:10.6061/clinics/2017(06)08NLM
Callefi LA, Villela-Nogueira CA, Tenore S de B, Carnaúba-Júnior D, Coelho HSM, Pinto P de TA, Nabuco LC, Pessôa MG, Ferraz MLCG, Ferreira PRA, Martinelli A de LC, Chachá SGF, Ferreira A de SP, Bisio AP de M, Brandão-Mello CE, Álvares-da-Silva MR, Reuter T, Ivantes CAP, Perez R de M, Mendes-Côrrea MCJ. Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study [Internet]. Clinics. 2017 ; 72( 6): 378-385.[citado 2024 ago. 22 ] Available from: https://doi.org/10.6061/clinics/2017(06)08Vancouver
Callefi LA, Villela-Nogueira CA, Tenore S de B, Carnaúba-Júnior D, Coelho HSM, Pinto P de TA, Nabuco LC, Pessôa MG, Ferraz MLCG, Ferreira PRA, Martinelli A de LC, Chachá SGF, Ferreira A de SP, Bisio AP de M, Brandão-Mello CE, Álvares-da-Silva MR, Reuter T, Ivantes CAP, Perez R de M, Mendes-Côrrea MCJ. Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study [Internet]. Clinics. 2017 ; 72( 6): 378-385.[citado 2024 ago. 22 ] Available from: https://doi.org/10.6061/clinics/2017(06)08